FDA Letter API

Chi's Enterprise Inc

Letter data

Company
Chi's Enterprise Inc
Recipient
Ms. Weijia D. Chi | President and Owner | Chi's Enterprise Inc | 1435 North Brasher St. | Anaheim | , | CA | 92807 | United States
Issue date
2020-04-08
Posted date
Not available
FDA office
Office of Human and Animal Food Operations West Division 5
Subject
Not available
Product
Dietary Supplements
CMS ID
542724
Reference number
542724-18
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Chi's Enterprise Inc MARCS-CMS 542724 — April 08, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Reference #: 542724-18 Product: Dietary Supplements Recipient: Recipient Name Ms. Weijia D. Chi Recipient Title President and Owner Chi's Enterprise Inc 1435 North Brasher St. Anaheim , CA 92807 United States Issuing Office: Office of Human and Animal Food Operations West Division 5 United States Dear Ms. Chi: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter #542724-18 dated April 30, 2018. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Sergio Chavez, Compliance Branch Director Office of Human and Animal Food Operations West Division 5 Content current as of: 04/24/2020 Regulated Product(s) Dietary Supplements